tradingkey.logo

Bio Rad Laboratories Inc

BIO
319.550USD
+15.080+4.95%
Cierre 10/31, 16:00ETCotizaciones retrasadas 15 min
8.62BCap. mercado
PérdidaP/E TTM

Bio Rad Laboratories Inc

319.550
+15.080+4.95%

Más Datos de Bio Rad Laboratories Inc Compañía

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Información de Bio Rad Laboratories Inc

Símbolo de cotizaciónBIO
Nombre de la empresaBio Rad Laboratories Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Norman D. Schwartz
Número de empleados7700
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1000 Alfred Nobel Dr
CiudadHERCULES
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94547
Teléfono15107247000
Sitio Webhttps://www.bio-rad.com/
Símbolo de cotizaciónBIO
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Norman D. Schwartz

Ejecutivos de Bio Rad Laboratories Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: jue., 30 de oct
Actualizado: jue., 30 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
Otro
58.55%
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
Otro
58.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
42.47%
Investment Advisor
38.94%
Individual Investor
8.27%
Corporation
8.13%
Hedge Fund
7.04%
Research Firm
1.67%
Pension Fund
1.24%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.63%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1080
20.35M
92.90%
-2.73M
2025Q2
1116
24.14M
109.77%
-3.54M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Eagle Investment Management, L.L.C.
2.52M
11.45%
+223.05K
+9.72%
Jun 30, 2025
The Vanguard Group, Inc.
1.84M
8.38%
-59.61K
-3.13%
Jun 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.1%
--
--
May 01, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
7.02%
-98.58K
-6.00%
Jun 30, 2025
Schwartz (Norman D)
447.98K
2.04%
+5.20K
+1.17%
Sep 06, 2025
Dimensional Fund Advisors, L.P.
999.57K
4.55%
+122.53K
+13.97%
Jun 30, 2025
Veritas Asset Management LLP
863.14K
3.92%
-49.98K
-5.47%
Jun 30, 2025
Ariel Investments, LLC
818.62K
3.72%
+93.96K
+12.97%
Jun 30, 2025
EARNEST Partners, LLC
605.89K
2.75%
+6.26K
+1.04%
Jun 30, 2025
State Street Investment Management (US)
584.37K
2.66%
-110.15K
-15.86%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: hace 7 horas
Actualizado: hace 7 horas
Nombre
Proporción
Parnassus Value Select ETF
3.15%
First Trust Indxx Medical Devices ETF
2.2%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Schwab Ariel Opportunities ETF
1.25%
FPA Global Equity ETF
1.21%
First Eagle Global Equity ETF
1.08%
Pacer US Export Leaders ETF
1.01%
WisdomTree BioRevolution Fund
0.85%
iShares Health Innovation Active ETF
0.84%
Harbor Health Care ETF
0.75%
Ver más
Parnassus Value Select ETF
Proporción3.15%
First Trust Indxx Medical Devices ETF
Proporción2.2%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.46%
Schwab Ariel Opportunities ETF
Proporción1.25%
FPA Global Equity ETF
Proporción1.21%
First Eagle Global Equity ETF
Proporción1.08%
Pacer US Export Leaders ETF
Proporción1.01%
WisdomTree BioRevolution Fund
Proporción0.85%
iShares Health Innovation Active ETF
Proporción0.84%
Harbor Health Care ETF
Proporción0.75%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI